ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ANEB Anebulo Pharmaceuticals Inc

2.87
0.09 (3.24%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Anebulo Pharmaceuticals Financial Summary

The current ANEB market cap is 74.43M. The company's latest EPS is USD -0.4524 and P/E is -6.81.

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -3.81M-2.86M-2.49M-2.54M-2.76M
Net Income -3.83M-2.8M-2.5M-2.48M-2.72M
Year End June 29 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Total Revenue 0000
Operating Income -174k-3.61M-6.83M-11.78M
Net Income -175k-38.46M-6.83M-11.73M
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)
Total Assets 16.89M14.43M11.67M9.05M7.5M
Total Liabilities 1.37M1.49M1.07M717k1.01M
Total Equity 15.52M12.94M10.6M8.33M6.49M
Year End June 29 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Total Assets 3.03M21.65M15.58M11.67M
Total Liabilities 224k242k513k1.07M
Total Equity -171k21.41M15.07M10.6M
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)
Operating -4.64M-6.84M-9.68M-2.73M-4.54M
Investing N/A N/A N/A N/A N/A
Financing 6.45M6.45M6.38M N/A -62k
Year End June 29 2023 2020202120222023
USD ($)USD ($)USD ($)USD ($)
Operating -151k-4.87M-5.44M-9.68M
Investing N/A N/A N/A N/A
Financing 3.18M21.83M N/A 6.38M
Market Cap 74.43M
Price to Earnings Ratio -6.81
Price to Sales Ratio 0
Price to Cash Ratio 7.1
Price to Book Ratio 7.53
Dividend Yield -

Share Statistics

Shares Outstanding 25.93M
Average Volume (1 week) 4.23k
Average Volume (1 Month) 5.4k
52 Week Change 0.00%
52 Week High 4.05
52 Week Low 1.62
Spread (Intraday) 0.88 (24.51%)

Company Info

Company Name Anebulo Pharmaceuticals Inc
Address 838 walker road
dover, delaware 19904
Website https://www.anebulo.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock